147 related articles for article (PubMed ID: 29181155)
1. Comparison of the effect of the aerobic glycolysis inhibitor dichloroacetate and of the Krebs cycle inhibitor LW6 on cellular and humoral alloimmunity.
Eleftheriadis T; Pissas G; Mavropoulos A; Liakopoulos V; Stefanidis I
Biomed Rep; 2017 Nov; 7(5):439-444. PubMed ID: 29181155
[TBL] [Abstract][Full Text] [Related]
2. A comparative analysis between proteasome and immunoproteasome inhibition in cellular and humoral alloimmunity.
Eleftheriadis T; Pissas G; Antoniadi G; Liakopoulos V; Stefanidis I
Int Immunopharmacol; 2017 Sep; 50():48-54. PubMed ID: 28628770
[TBL] [Abstract][Full Text] [Related]
3. In human cell cultures, everolimus is inferior to tacrolimus in inhibiting cellular alloimmunity, but equally effective as regards humoral alloimmunity.
Eleftheriadis T; Pissas G; Sounidaki M; Antoniadi G; Antoniadis N; Liakopoulos V; Stefanidis I
Int Urol Nephrol; 2017 Sep; 49(9):1691-1697. PubMed ID: 28508247
[TBL] [Abstract][Full Text] [Related]
4. Uric acid increases cellular and humoral alloimmunity in primary human peripheral blood mononuclear cells.
Eleftheriadis T; Pissas G; Sounidaki M; Antoniadi G; Antoniadis N; Liakopoulos V; Stefanidis I
Nephrology (Carlton); 2018 Jul; 23(7):610-615. PubMed ID: 28477373
[TBL] [Abstract][Full Text] [Related]
5. Malate dehydrogenase-2 inhibitor LW6 promotes metabolic adaptations and reduces proliferation and apoptosis in activated human T-cells.
Eleftheriadis T; Pissas G; Antoniadi G; Liakopoulos V; Stefanidis I
Exp Ther Med; 2015 Nov; 10(5):1959-1966. PubMed ID: 26640580
[TBL] [Abstract][Full Text] [Related]
6. Indoleamine 2,3-dioxygenase suppresses humoral alloimmunity via pathways that different to those associated with its effects on T cells.
Sounidaki M; Pissas G; Eleftheriadis T; Antoniadi G; Golfinopoulos S; Liakopoulos V; Stefanidis I
Biomed Rep; 2019 Jun; 1(1):1-5. PubMed ID: 31258898
[TBL] [Abstract][Full Text] [Related]
7. Assessment of Humoral Alloimmunity in Mixed Lymphocyte Reaction.
Pissas G; Eleftheriadis T
Bio Protoc; 2019 Jan; 9(2):e3139. PubMed ID: 33654885
[TBL] [Abstract][Full Text] [Related]
8. In human alloreactive CD4⁺ T-cells, dichloroacetate inhibits aerobic glycolysis, induces apoptosis and favors differentiation towards the regulatory T-cell subset instead of effector T-cell subsets.
Eleftheriadis T; Sounidaki M; Pissas G; Antoniadi G; Liakopoulos V; Stefanidis I
Mol Med Rep; 2016 Apr; 13(4):3370-6. PubMed ID: 26935268
[TBL] [Abstract][Full Text] [Related]
9. Dichloroacetate at therapeutic concentration alters glucose metabolism and induces regulatory T-cell differentiation in alloreactive human lymphocytes.
Eleftheriadis T; Pissas G; Karioti A; Antoniadi G; Antoniadis N; Liakopoulos V; Stefanidis I
J Basic Clin Physiol Pharmacol; 2013; 24(4):271-6. PubMed ID: 23612652
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of indoleamine 2,3-dioxygenase in mixed lymphocyte reaction affects glucose influx and enzymes involved in aerobic glycolysis and glutaminolysis in alloreactive T-cells.
Eleftheriadis T; Pissas G; Yiannaki E; Markala D; Arampatzis S; Antoniadi G; Liakopoulos V; Stefanidis I
Hum Immunol; 2013 Dec; 74(12):1501-9. PubMed ID: 23993986
[TBL] [Abstract][Full Text] [Related]
11. mTOR Inhibition Suppresses Posttransplant Alloantibody Production Through Direct Inhibition of Alloprimed B Cells and Sparing of CD8+ Antibody-Suppressing T cells.
Avila CL; Zimmerer JM; Elzein SM; Pham TA; Abdel-Rasoul M; Bumgardner GL
Transplantation; 2016 Sep; 100(9):1898-906. PubMed ID: 27362313
[TBL] [Abstract][Full Text] [Related]
12. Indoleamine 2,3-dioxygenase increases p53 levels in alloreactive human T cells, and both indoleamine 2,3-dioxygenase and p53 suppress glucose uptake, glycolysis and proliferation.
Eleftheriadis T; Pissas G; Antoniadi G; Spanoulis A; Liakopoulos V; Stefanidis I
Int Immunol; 2014 Dec; 26(12):673-84. PubMed ID: 25064493
[TBL] [Abstract][Full Text] [Related]
13. In vitro effects of dichloroacetate and CO2 on hypoxic HeLa cells.
Anderson KM; Jajeh J; Guinan P; Rubenstein M
Anticancer Res; 2009 Nov; 29(11):4579-88. PubMed ID: 20032407
[TBL] [Abstract][Full Text] [Related]
14. T Follicular Helper Cells As a New Target for Immunosuppressive Therapies.
Yan L; de Leur K; Hendriks RW; van der Laan LJW; Shi Y; Wang L; Baan CC
Front Immunol; 2017; 8():1510. PubMed ID: 29163552
[TBL] [Abstract][Full Text] [Related]
15. Dichloroacetate shifts the metabolism from glycolysis to glucose oxidation and exhibits synergistic growth inhibition with cisplatin in HeLa cells.
Xie J; Wang BS; Yu DH; Lu Q; Ma J; Qi H; Fang C; Chen HZ
Int J Oncol; 2011 Feb; 38(2):409-17. PubMed ID: 21132264
[TBL] [Abstract][Full Text] [Related]
16. Metabolic Modulation of Clear-cell Renal Cell Carcinoma with Dichloroacetate, an Inhibitor of Pyruvate Dehydrogenase Kinase.
Kinnaird A; Dromparis P; Saleme B; Gurtu V; Watson K; Paulin R; Zervopoulos S; Stenson T; Sutendra G; Pink DB; Carmine-Simmen K; Moore R; Lewis JD; Michelakis ED
Eur Urol; 2016 Apr; 69(4):734-744. PubMed ID: 26433571
[TBL] [Abstract][Full Text] [Related]
17. Dichloroacetate alters Warburg metabolism, inhibits cell growth, and increases the X-ray sensitivity of human A549 and H1299 NSC lung cancer cells.
Allen KT; Chin-Sinex H; DeLuca T; Pomerening JR; Sherer J; Watkins JB; Foley J; Jesseph JM; Mendonca MS
Free Radic Biol Med; 2015 Dec; 89():263-73. PubMed ID: 26393423
[TBL] [Abstract][Full Text] [Related]
18. Specific MDR1 P-glycoprotein blockade inhibits human alloimmune T cell activation in vitro.
Frank MH; Denton MD; Alexander SI; Khoury SJ; Sayegh MH; Briscoe DM
J Immunol; 2001 Feb; 166(4):2451-9. PubMed ID: 11160305
[TBL] [Abstract][Full Text] [Related]
19. Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation.
Kumar A; Kant S; Singh SM
Toxicol Appl Pharmacol; 2013 Nov; 273(1):196-208. PubMed ID: 24051182
[TBL] [Abstract][Full Text] [Related]
20. Discovery of LW6 as a new potent inhibitor of breast cancer resistance protein.
Song JG; Lee YS; Park JA; Lee EH; Lim SJ; Yang SJ; Zhao M; Lee K; Han HK
Cancer Chemother Pharmacol; 2016 Oct; 78(4):735-44. PubMed ID: 27520631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
